News & Events

Cognizin® Citicoline Receives Frost & Sullivan Award

March 22, 2011

New York, NY – Cognizin® Citicoline, a brain health ingredient from Kyowa Hakko USA, has received the 2010 Frost & Sullivan "Product Differentiation Excellence" award in the cognitive health ingredients category for its brain-supporting properties proven through relevant science and increasing market popularity.

The Product Differentiation Excellence of the Year Award was the result of a product's performance in five areas:  Features/Functionality, Research Excellence, Strategies to Enhance Market Reach, Customer/Consumer Value Enhancements and Addressing Market Need. Of products considered for the category, Cognizin rated highest in each area.

"Cognizin's unusual ability to cross the blood-brain barrier to enhance communication between brain neurons; extensive science conducted at research institutions including the Brain Institute at the University of Utah and McLean Hospital, an affiliate of Harvard University; and expansive co-branding programs make it an award-worthy ingredient," said Leo Cullen, vice president of sales and marketing at Kyowa Hakko USA. "We are proud to receive this Frost & Sullivan product differentiation award and are honored that the committee found Cognizin's attributes extraordinary."

More About Cognizin

Cognizin is a branded form of Citicoline, a natural substance found in every cell of the body and especially vital to brain health.* Citicoline is broken down during intestinal absorption and, after passing through the blood/brain barrier, is reconstituted in the brain as citicoline.* Citicoline is a water-soluble compound that supplies precursors for the synthesis of phospholipids, including phosphatidyl- choline, a major constituent of brain tissue*; helps maintain normal levels of acetylcholine, a chemical that regulates memory and cognitive function*; enhances communication between neurons*; supports visual function*; protects neural structures from free radical damage*; enhances metabolism and healthy brain activity*; and helps sustain healthy cellular mitochondria for sustained energy*. Cognizin is also highly stable, GRAS, ultra-pure and allergen-free. For more information on Cognizin, visit

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit

About Kyowa Hakko USA

Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin(R) Citicoline, Hydrafend™ Hyaluronic Acid, Lumistor® L-Hydroxyproline, Setria® Glutathione, Kyowa CoQ10™ as well as Sustamine™ L-Alanyl-L-Glutamine.

# # #

Courtney Jacobs Morton
Integrated Marketing Group
P: 801-538-0777 x102

‹ Back to 2011